Trial intelligence / Profile preview

N-acetylcysteine for prevention or treatment of threatened preterm labor

2017-003999-31Phase 3Terminated

Sponsor
CHU de Nantes
Start
Dec 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of acetylcysteine in Preterm labor (PTL), sponsored by CHU de Nantes. Started Dec 2017; status: terminated.

02

Drugs

acetylcysteine
03

Conditions

Preterm labor (PTL)

Beyond the preview

Go deeper on 2017-003999-31.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2017-003999-31.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call